Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Leukemia, Myeloid, Acute 3Leukemia 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Congenital Abnormalities 2Testicular Neoplasms 1Testicular Germ Cell Tumor 1Teratoma, Testicular 1Skin Neoplasms 1Pancreatic Neoplasms 1Neoplasms, Plasma Cell 1Myelodysplastic Syndromes 1Multiple Myeloma 1Melanoma 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Kidney Neoplasms 1Graft vs Host Disease 1Carcinoma, Renal Cell 1Blast Crisis 1

Interventions

In Situ Hybridization 1Immunologic Techniques 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Teratoma, Testicular × Immunologic Techniques × Clear all
NCT00899132 2015-09-29

Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer

Case Comprehensive Cancer Center

Terminated
180 enrolled
DermatologicGastrointestinalGenitourinary

Teratoma, Testicular, Testicular Germ Cell Tumor, Pancreatic Neoplasms, Skin Neoplasms, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡